IL-10 and TGF-β redundantly protect against severe liver injury and mortality during acute schistosomiasis

Journal of Immunology

Volumn 181, Issue 10, 2008, Pages 7214-7220

  Herbert, De'Broski R ^a,b   Orekov, Tatyana ^a,b   Perkins, Charles ^a,c   Finkelman, Fred D ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACHEXIA; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EGG PRODUCTION; ENTEROPATHY; HEPATITIS; INJURY SEVERITY; LIVER GRANULOMA; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; LYMPHOCYTE COUNT; MACROPHAGE ACTIVATION; MALE; MORTALITY; MOUSE; NEUTROPHILIA; NONHUMAN; PERITONEAL DISEASE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPLEEN DISEASE; ANIMAL; BAGG ALBINO MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; LIVER DISEASE; MACROPHAGE; METABOLISM; MICROBIOLOGY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INTERLEUKIN-10; LIVER DISEASES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHISTOSOMIASIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 58149200168     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.10.7214     Document Type: Article

References (51)

1. Wan, Y. Y., and R. A. Flavell. 2007. "Yin-Yang" functions of transforming growth factor-β and T regulatory cells in immune regulation. Immunol. Rev. 220: 199-213. (Pubitemid 350064011)
2. + Tregs: limiting collateral damage. J. Clin. Invest. 114: 1372-1378.
3. Dunne, D. W., and E. J. Pearce. 1999. Immunology of hepatosplenic schistosomiasis mansoni: a human perspective. Microbes Infect. 1: 553-560.
4. Abath, F. G., C. N. Morais, C. E. Montenegro, T. A. Wynn, and S. M. Montenegro. 2006. Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies? Trends Parasitol. 22: 85-91. (Pubitemid 43145868)
5. Stadecker, M. J. 1994. The shrinking schistosomal egg granuloma: how accessory cells control T cell-mediated pathology. Exp. Parasitol. 79: 198-201.
6. de Jesus, A. R., A. Magalhaes, D. G. Miranda, R. G. Miranda, M. I. Araujo, A. A. de Jesus, A. Silva, L. B. Santana, E. Pearce, and E. M. Carvalho. 2004. Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect. Immun. 72: 3391-3397.
7. Chiaramonte, M. G., A. W. Cheever, J. D. Malley, D. D. Donaldson, and T. A. Wynn. 2001. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology 34: 273-282.
8. La Flamme, A. C., E. A. Patton, B. Bauman, and E. J. Pearce. 2001. IL-4 plays a crucial role in regulating oxidative damage in the liver during schistosomiasis. J. Immunol. 166: 1903-1911.
9. Hoffmann, K. F., A. W. Cheever, and T. A. Wynn. 2000. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J. Immunol. 164: 6406-6416.
10. Rutitzky, L. I., and M. J. Stadecker. 2006. CD4 T cells producing pro-inflammatory interleukin-17 mediate high pathology in schistosomiasis. Mem. Inst. Oswaldo Cruz 101 (Suppl. 1): 327-330.
11. Stadecker, M. J., H. Asahi, E. Finger, H. J. Hernandez, L. I. Rutitzky, and J. Sun. 2004. The immunobiology of Th1 polarization in high-pathology schistosomiasis. Immunol. Rev. 201: 168-179.
12. Herbert, D. R., C. Holscher, M. Mohrs, B. Arendse, A. Schwegmann, M. Radwanska, M. Leeto, R. Kirsch, P. Hall, H. Mossmann, et al. 2004. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20: 623-635. (Pubitemid 38659504)
13. Herbert, D. R., T. Orekov, C. Perkins, M. E. Rothenberg, and F. D. Finkelman. 2008. IL-4R α expression by bone marrow-derived cells is necessary and sufficient for host protection against acute schistosomiasis. J. Immunol. 180: 4948-4955.
14. Cheever, A. W., K. F. Hoffmann, and T. A. Wynn. 2000. Immunopathology of schistosomiasis mansoni in mice and men. Immunol. Today 21: 465-466. (Pubitemid 30693867)
15. Pearce, E. J., and A. S. MacDonald. 2002. The immunobiology of schistosomiasis. Nat. Rev. Immunol. 2: 499-511.
16. Li, M. O., Y. Y. Wan, and R. A. Flavell. 2007. T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26: 579-591.
17. Wan, Y. Y., and R. A. Flavell. 2006. The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol. Rev. 212: 114-130. (Pubitemid 44116704)
18. Kriegel, M. A., M. O. Li, S. Sanjabi, Y. Y. Wan, and R. A. Flavell. 2006. Transforming growth factor-β: recent advances on its role in immune tolerance. Curr. Rheumatol. Rep. 8: 138-144.
19. Farah, I. O., P. W. Mola, T. M. Kariuki, M. Nyindo, R. E. Blanton, and C. L. King. 2000. Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-β and IL-4. J. Immunol. 164: 5337-5343.
20. Hernandez, H. J., L. I. Rutitzky, M. Lebens, J. Holmgren, and M. J. Stadecker. 2002. Diminished immunopathology in Schistosoma mansoni infection following intranasal administration of cholera toxin B-immunodominant peptide conjugate correlates with enhanced transforming growth factor-β production by CD4 T cells. Parasite Immunol. 24: 423-427.
21. Oswald, I. P., T. A. Wynn, A. Sher, and S. L. James. 1992. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor α required as a costimulatory factor for interferon γ-induced activation. Proc. Natl. Acad. Sci. USA 89: 8676-8680.
22. Hesse, M., C. A. Piccirillo, Y. Belkaid, J. Prufer, M. Mentink-Kane, M. Leusink, A. W. Cheever, E. M. Shevach, and T. A. Wynn. 2004. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol. 172: 3157-3166. (Pubitemid 38263706)
23. Ince, M. N., D. E. Elliott, T. Setiawan, A. Blum, A. Metwali, Y. Wang, J. F. Urban, Jr., and J. V. Weinstock. 2006. Heligmosomoides polygyrus induces TLR4 on murine mucosal T cells that produce TGFβ after lipopolysaccharide stimulation. J. Immunol. 176: 726-729.
24. Kuroda, E., Y. Yoshida, B. En Shan, and U. Yamashita. 2001. Suppression of macrophage interleukin-12 and tumour necrosis factor-α production in mice infected with Toxocara canis. Parasite Immunol. 23: 305-311. (Pubitemid 34298019)
25. Omer, F. M., J. A. Kurtzhals, and E. M. Riley. 2000. Maintaining the immunological balance in parasitic infections: a role for TGF-β? Parasitol. Today 16: 18-23.
26. Corbi, A. L., T. K. Kishimoto, L. J. Miller, and T. A. Springer. 1988. The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) α subunit: cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B. J. Biol. Chem. 263: 12403-12411.
27. Fleming, T. J., M. L. Fleming, and T. R. Malek. 1993. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151: 2399-2408.
28. Finkelman, F., S. Morris, T. Orekhova, and D. Sehy. 2003. The in vivo cytokine capture assay for measurement of cytokine production in the mouse. In Current Protocols in Immunolgy. J. Coligan, A. Kruisbeek, D. Margulies, E. Shevach, and W. Strober, eds. John Wiley and Sons, New York, Chapter 6: Unit 6.28.
29. Leeto, M., D. R. Herbert, R. Marillier, A. Schwegmann, L. Fick, and F. Brombacher. 2006. TH1-dominant granulomatous pathology does not inhibit fibrosis or cause lethality during murine schistosomiasis. Am. J. Pathol. 169: 1701-1712. (Pubitemid 351182001)
30. Sadler, C. H., L. I. Rutitzky, M. J. Stadecker, and R. A. Wilson. 2003. IL-10 is crucial for the transition from acute to chronic disease state during infection of mice with Schistosoma mansoni. Eur. J. Immunol. 33: 880-888.
31. Stadecker, M. J., J. K. Kamisato, and S. M. Chikunguwo. 1990. Induction of T helper cell unresponsiveness to antigen by macrophages from schistosomal egg granulomas: a basis for immunomodulation in schistosomiasis? J. Immunol. 145: 2697-2700.
32. Loke, P., M. G. Nair, J. Parkinson, D. Guiliano, M. Blaxter, and J. E. Allen. 2002. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol. 3: 7. (Pubitemid 38692919)
33. + T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J. Immunol. 177: 5868-5877.
34. + regulatory T cells. Nat. Immunol. 9: 632-640.
35. + cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J. Immunol. 173: 1224-1231.
36. Taylor, J. J., M. Mohrs, and E. J. Pearce. 2006. Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J. Immunol. 176: 5839-5847.
37. Schopf, L. R., K. F. Hoffmann, A. W. Cheever, J. F. Urban, Jr., and T. A. Wynn. 2002. IL-10 is critical for host resistance and survival during gastrointestinal helminth infection. J. Immunol. 168: 2383-2392.
38. Anderson, C. F., R. Lira, S. Kamhawi, Y. Belkaid, T. A. Wynn, and D. Sacks. 2008. IL-10 and TGF-β control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice. J. Immunol. 180: 4090-4097.
39. Oswald, I. P., R. T. Gazzinelli, A. Sher, and S. L. James. 1992. IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J. Immunol. 148: 3578-3582.
40. Toms, C., and F. Powrie. 2001. Control of intestinal inflammation by regulatory T cells. Microbes Infect. 3: 929-935. (Pubitemid 32835307)
41. Fuss, I. J., M. Boirivant, B. Lacy, and W. Strober. 2002. The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis. J. Immunol. 168: 900-908.
42. Di Giacinto, C., M. Marinaro, M. Sanchez, W. Strober, and M. Boirivant. 2005. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. J. Immunol. 174: 3237-3246. (Pubitemid 40354026)
43. Beiting, D. P., L. F. Gagliardo, M. Hesse, S. K. Bliss, D. Meskill, and J. A. Appleton. 2007. Coordinated control of immunity to muscle stage Trichinella spiralis by IL-10, regulatory T cells, and TGF-β. J. Immunol. 178: 1039-1047.
44. Munitz, A., E. B. Brandt, M. Mingler, F. D. Finkelman, and M. E. Rothenberg. 2008. Distinct roles for IL-13 and IL-4 via IL-13 receptor α1 and the type II IL-4 receptor in asthma pathogenesis. Proc. Natl. Acad. Sci. USA 105: 7240-7245. (Pubitemid 351754462)
45. Yu, J. J., M. J. Ruddy, G. C. Wong, C. Sfintescu, P. J. Baker, J. B. Smith, R. T. Evans, and S. L. Gaffen. 2007. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109: 3794-3802.
46. McGeachy, M. J., and D. J. Cua. 2008. Th17 cell differentiation: the long and winding road. Immunity 28: 445-453.
47. McGeachy, M. J., and D. J. Cua. 2007. The link between IL-23 and Th17 cell-mediated immune pathologies. Semin. Immunol. 19: 372-376.
48. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
49. + T cells during Schistosoma mansoni infection of mice. Parasite Immunol. 29: 293-308.
50. Seoane, J. 2008. The TGFβ pathway as a therapeutic target in cancer. Clin. Transl. Oncol. 10: 14-19.
51. Llorente, L., Y. Richaud-Patin, C. Garcia-Padilla, E. Claret, J. Jakez-Ocampo, M. H. Cardiel, J. Alcocer-Varela, L. Grangeot-Keros, D. Alarcon-Segovia, J. Wijdenes, et al. 2000. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum. 43: 1790-1800.